DeNDRoN and NIHR Logos DeNDRoN Home Page www.nihr.ac.uk

  • Home
  • Research Networks
    • East Anglia
    • North East
    • North West
    • North Thames
    • South Coast
    • South West
    • Thames Valley
    • Supplementary Resources
  • Study Development
    • Clinical Studies Groups
    • Task Forces
    • Writing Groups
  • Patient and Public Involvement
    • PPI documents
    • Aims & Objectives
    • Background
    • Co-ordination
    • PPI Forum
    • Principles
    • What does PPI mean?
    • PPI Working Group
    • Registering your interest
  • Industry
    • Adoption
    • Background
    • Benefits
    • Collaboration
    • FAQ
    • Industry Support
    • Non-commercial
    • NIHR Industry
  • News
  • Events
  • Vacancies
    • Leadership Roles
    • Local Research Network Staff
    • Co-ordinating Centre Staff
  • About
    • About DeNDRoN
    • Co-ordinating Centre
    • Targets
    • Contact us
    • Conferences
    • Portal

Latest News

Largest genetic study confirms importance of chromosome 9 in MND

Cause for optimism during Dementia Awareness Week

Professor John O’Brien and Professor David Burn join the Co-ordinating Centre leadership team as Associate Directors

Search launched for new National Leads for Dementia And Parkinson’s disease

Dr Cath Mummery appointed as acting Clinical Lead for North Thames DeNDRoN

DeNDRoN Director appointed as the new National Clinical Director for Dementia

More news items

DeNDRoN RSS News

The Same Page - DeNDRoN Newsletter

Summer 2010 pdf

Winter 2009/2010 pdf

Spring 2009 pdf

December 2008 pdf

September 2008 pdf

July 2008 pdf

 


Links

DeNDRoN Portal

NIHR CRN Co-ordinating Centre

NIHR

DeNDRoN Portfolio

Non-Commercial Portfolio Submission form

NIHR Portfolio Eligibility Criteria

Industry Trials Submission Form

Alzheimer's Society

Parkinson's UK

MND Association

Huntington's Disease Association

Alzheimer's Research Trust

University College London

Newcastle University

Welcome to the
Dementias & Neurodegenerative Diseases
Research Network website

The NIHR Dementias & Neurodegenerative Diseases Research Network (NIHR DeNDRoN) is one of six topic-specific Clinical Research Networks funded by the Department of Health in England as part of the National Institute for Health Research. NIHR DeNDRoN supports the development and delivery of clinical research in the NHS in the dementias, Parkinson’s disease, motor neurone disease, Huntington’s disease and other neurodegenerative diseases.

How does DeNDRoN support the development of new clinical research?

DeNDRoN provides financial and administrative support to the research community to support the collaborative development and writing of new research grant applications. Click here for further information.

How does DeNDRoN support the delivery of clinical research?

DeNDRoN provides the NHS infrastructure in England to support clinical research through its seven Local Research Networks and collaboration with the NIHR Comprehensive Local Research Networks. Click here for further information.

What research does DeNDRoN support?

DeNDRoN supports the conduct of randomised controlled trials of interventions (including prevention, diagnosis, treatment, and care) and other well designed studies for commercial and non-commercial sponsors.  DeNDRoN only supports studies that are included on the NIHR Portfolio. Eligibility criteria are available at:
http://www.ukcrn.org.uk/index/clinical/portfolio_new/P_eligibility

 


 

 



London Office (General Enquiries)
DeNDRoN Co-ordinating Centre
Wolfson Centre
Mecklenburgh Square
LONDON
WC1N 2AP

Tel: +44 (0)20 7905 2995
Fax: +44 (0)20 7905 2959



Back to top

Newcastle Office (Portfolio Enquiries)
Wolfson Research Centre
Institute for Ageing and Health
Newcastle University
Campus for Ageing and Vitality
NEWCASTLE UPON TYNE
NE4 5PL
Tel:  +44 (0)191 248 1347
Fax: +44 (0)191 248 1301

© DeNDRoN 2010



info@dendron.org.uk